400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cell Cycle / Aurora Kinase / PF-03814735
CAS No.: 942487-16-3
Synonyms: Pf-03814735
PF-03814735 is a potent, orally bioavailable, reversible small-molecule Aurora kinase inhibitor with IC50 of 0.8, 5, 10 and 22 nM for Aurora A, Aurora B, Flt 1 and FAk, respectively.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00424632 | Solid Tumors | Phase 1 | Completed | - | United States, Tennessee ... more >> Pfizer Investigational Site Nashville, Tennessee, United States, 37203 Belgium Pfizer Investigational Site Leuven, Belgium, 3000 Collapse << |
NCT00424632 | - | - | Completed | - | - |
实验方案
技术信息
CAS号 | 942487-16-3 | 储存条件 |
|
|
分子式 | C23H25F3N6O2 | 运输 | 蓝冰 | |
分子量 | 474.48 | 别名 | Pf-03814735 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00424632 | Solid Tumors | Phase 1 | Completed | - | United States, Tennessee ... more >> Pfizer Investigational Site Nashville, Tennessee, United States, 37203 Belgium Pfizer Investigational Site Leuven, Belgium, 3000 Collapse << |
NCT00424632 | - | - | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网